Katoh A, Nabeshima T, Kameyama T
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya, Japan.
J Pharmacol Exp Ther. 1990 May;253(2):600-7.
Effects of opioid peptides on behavioral changes induced by stressful situations were investigated. [D-Ala2,Met5]-enkephalinamide and [D-Ala2,D-Leu5]-enkephalin, degrading-enzyme-resistant derivatives of methionine-enkephalin and leucine-enkephalin, respectively, significantly attenuated both environment-induced conditioned suppression of motility and forced swimming-induced immobility in a dose-dependent manner. The [D-Ala2,Met5]-enkephalinamide- and [D-Ala2,D-Leu5]-enkephalin-induced attenuations were antagonized by naloxone at different doses. In contrast, dynorphin A(1-17) and [N-methyl-Tyr1,N-methyl-Arg7,D-Leu8]-dynorphin A(1-8) ethylamide (E 2078), a degrading-enzyme-resistant derivative of dynorphin, significantly potentiated both behavioral changes. The dynorphin- and E 2078-induced potentiations were inhibited by Mr 2266. [D-Ala2,Met5]-enkephalinamide-induced attenuation of environment-induced conditioned suppression of motility and forced swimming-induced immobility was prevented by treatment with dynorphin and E 2078 at the doses that did not affect the behavioral changes. This antagonism by both dynorphin and E 2078 was inhibited by Mr 2266. However, [D-Ala2,D-Leu5]-enkephalin-induced attenuation of both behavioral changes was not affected by either dynorphin or E 2078. These results indicated that activation of the methionine- or leucine-enkephalinergic system attenuates behavioral changes induced by stress, whereas activation of the dynorphinergic system potentiates those changes. Furthermore, the dynorphinergic system may interact with the methionine-enkephalinergic system, but not with the leucine-enkephalinergic system.
研究了阿片肽对应激情况下行为变化的影响。[D-丙氨酸2,甲硫氨酸5]-脑啡肽酰胺和[D-丙氨酸2,D-亮氨酸5]-脑啡肽,分别是甲硫氨酸脑啡肽和亮氨酸脑啡肽的抗降解酶衍生物,以剂量依赖的方式显著减弱了环境诱导的运动条件性抑制和强迫游泳诱导的不动。不同剂量的纳洛酮可拮抗[D-丙氨酸2,甲硫氨酸5]-脑啡肽酰胺和[D-丙氨酸2,D-亮氨酸5]-脑啡肽诱导的减弱作用。相比之下,强啡肽A(1-17)和[N-甲基-Tyr1,N-甲基-Arg7,D-亮氨酸8]-强啡肽A(1-8)乙酰胺(E 2078),一种强啡肽的抗降解酶衍生物,显著增强了这两种行为变化。强啡肽和E 2078诱导的增强作用被Mr 2266抑制。用不影响行为变化的剂量的强啡肽和E 2078处理可阻止[D-丙氨酸2,甲硫氨酸5]-脑啡肽酰胺诱导的环境诱导的运动条件性抑制和强迫游泳诱导的不动的减弱。强啡肽和E 2078的这种拮抗作用被Mr 2266抑制。然而,[D-丙氨酸2,D-亮氨酸5]-脑啡肽诱导的两种行为变化的减弱不受强啡肽或E 2078的影响。这些结果表明,甲硫氨酸或亮氨酸脑啡肽能系统的激活减弱了应激诱导的行为变化,而强啡肽能系统的激活则增强了这些变化。此外,强啡肽能系统可能与甲硫氨酸脑啡肽能系统相互作用,但不与亮氨酸脑啡肽能系统相互作用。